img

Global Intramuscular Vaccine Adjuvants Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intramuscular Vaccine Adjuvants Market Research Report 2024

Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
According to Mr Accuracy reports’s new survey, global Intramuscular Vaccine Adjuvants market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intramuscular Vaccine Adjuvants market research.
Key manufacturers engaged in the Intramuscular Vaccine Adjuvants industry include GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health and Associated British Foods, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Intramuscular Vaccine Adjuvants were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Intramuscular Vaccine Adjuvants market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intramuscular Vaccine Adjuvants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
Segment by Type
Infectious Diseases
Cancer
Others

Segment by Application


Research Applications
Commercial Applications

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intramuscular Vaccine Adjuvants report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Intramuscular Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Intramuscular Vaccine Adjuvants
1.2 Intramuscular Vaccine Adjuvants Segment by Type
1.2.1 Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2024-2034)
1.2.2 Infectious Diseases
1.2.3 Cancer
1.2.4 Others
1.3 Intramuscular Vaccine Adjuvants Segment by Application
1.3.1 Global Intramuscular Vaccine Adjuvants Market Value by Application: (2024-2034)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Intramuscular Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Intramuscular Vaccine Adjuvants Revenue 2018-2034
1.4.2 Global Intramuscular Vaccine Adjuvants Sales 2018-2034
1.4.3 Global Intramuscular Vaccine Adjuvants Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Intramuscular Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Intramuscular Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intramuscular Vaccine Adjuvants Average Price by Manufacturers (2018-2023)
2.4 Global Intramuscular Vaccine Adjuvants Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Product Type & Application
2.7 Intramuscular Vaccine Adjuvants Market Competitive Situation and Trends
2.7.1 Intramuscular Vaccine Adjuvants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intramuscular Vaccine Adjuvants Players Market Share by Revenue
2.7.3 Global Intramuscular Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intramuscular Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Intramuscular Vaccine Adjuvants Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Intramuscular Vaccine Adjuvants Global Intramuscular Vaccine Adjuvants Sales by Region: 2018-2034
3.2.1 Global Intramuscular Vaccine Adjuvants Sales by Region: 2018-2023
3.2.2 Global Intramuscular Vaccine Adjuvants Sales by Region: 2024-2034
3.3 Global Intramuscular Vaccine Adjuvants Global Intramuscular Vaccine Adjuvants Revenue by Region: 2018-2034
3.3.1 Global Intramuscular Vaccine Adjuvants Revenue by Region: 2018-2023
3.3.2 Global Intramuscular Vaccine Adjuvants Revenue by Region: 2024-2034
3.4 North America Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Intramuscular Vaccine Adjuvants Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Intramuscular Vaccine Adjuvants Sales by Country (2018-2034)
3.4.3 North America Intramuscular Vaccine Adjuvants Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Intramuscular Vaccine Adjuvants Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Intramuscular Vaccine Adjuvants Sales by Country (2018-2034)
3.5.3 Europe Intramuscular Vaccine Adjuvants Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Asia Pacific Intramuscular Vaccine Adjuvants Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Intramuscular Vaccine Adjuvants Sales by Country (2018-2034)
3.6.3 Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Intramuscular Vaccine Adjuvants Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Intramuscular Vaccine Adjuvants Sales by Country (2018-2034)
3.7.3 Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intramuscular Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular Vaccine Adjuvants Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Intramuscular Vaccine Adjuvants Sales by Country (2018-2034)
3.8.3 Middle East and Africa Intramuscular Vaccine Adjuvants Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular Vaccine Adjuvants Sales by Type (2018-2034)
4.1.1 Global Intramuscular Vaccine Adjuvants Sales by Type (2018-2023)
4.1.2 Global Intramuscular Vaccine Adjuvants Sales by Type (2024-2034)
4.1.3 Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2018-2034)
4.2 Global Intramuscular Vaccine Adjuvants Revenue by Type (2018-2034)
4.2.1 Global Intramuscular Vaccine Adjuvants Revenue by Type (2018-2023)
4.2.2 Global Intramuscular Vaccine Adjuvants Revenue by Type (2024-2034)
4.2.3 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2018-2034)
4.3 Global Intramuscular Vaccine Adjuvants Price by Type (2018-2034)
5 Segment by Application
5.1 Global Intramuscular Vaccine Adjuvants Sales by Application (2018-2034)
5.1.1 Global Intramuscular Vaccine Adjuvants Sales by Application (2018-2023)
5.1.2 Global Intramuscular Vaccine Adjuvants Sales by Application (2024-2034)
5.1.3 Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2018-2034)
5.2 Global Intramuscular Vaccine Adjuvants Revenue by Application (2018-2034)
5.2.1 Global Intramuscular Vaccine Adjuvants Revenue by Application (2018-2023)
5.2.2 Global Intramuscular Vaccine Adjuvants Revenue by Application (2024-2034)
5.2.3 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2018-2034)
5.3 Global Intramuscular Vaccine Adjuvants Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Intramuscular Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Dynavax Technologies
6.2.1 Dynavax Technologies Corporation Information
6.2.2 Dynavax Technologies Description and Business Overview
6.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dynavax Technologies Intramuscular Vaccine Adjuvants Product Portfolio
6.2.5 Dynavax Technologies Recent Developments/Updates
6.3 Novavax
6.3.1 Novavax Corporation Information
6.3.2 Novavax Description and Business Overview
6.3.3 Novavax Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novavax Intramuscular Vaccine Adjuvants Product Portfolio
6.3.5 Novavax Recent Developments/Updates
6.4 Agenus
6.4.1 Agenus Corporation Information
6.4.2 Agenus Description and Business Overview
6.4.3 Agenus Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Agenus Intramuscular Vaccine Adjuvants Product Portfolio
6.4.5 Agenus Recent Developments/Updates
6.5 Croda International
6.5.1 Croda International Corporation Information
6.5.2 Croda International Description and Business Overview
6.5.3 Croda International Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Croda International Intramuscular Vaccine Adjuvants Product Portfolio
6.5.5 Croda International Recent Developments/Updates
6.6 Seppic
6.6.1 Seppic Corporation Information
6.6.2 Seppic Description and Business Overview
6.6.3 Seppic Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Seppic Intramuscular Vaccine Adjuvants Product Portfolio
6.6.5 Seppic Recent Developments/Updates
6.7 OZ Biosciences
6.6.1 OZ Biosciences Corporation Information
6.6.2 OZ Biosciences Description and Business Overview
6.6.3 OZ Biosciences Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 OZ Biosciences Intramuscular Vaccine Adjuvants Product Portfolio
6.7.5 OZ Biosciences Recent Developments/Updates
6.8 Phibro Animal Health
6.8.1 Phibro Animal Health Corporation Information
6.8.2 Phibro Animal Health Description and Business Overview
6.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Phibro Animal Health Intramuscular Vaccine Adjuvants Product Portfolio
6.8.5 Phibro Animal Health Recent Developments/Updates
6.9 Associated British Foods
6.9.1 Associated British Foods Corporation Information
6.9.2 Associated British Foods Description and Business Overview
6.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Associated British Foods Intramuscular Vaccine Adjuvants Product Portfolio
6.9.5 Associated British Foods Recent Developments/Updates
6.10 InvivoGen
6.10.1 InvivoGen Corporation Information
6.10.2 InvivoGen Description and Business Overview
6.10.3 InvivoGen Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.10.4 InvivoGen Intramuscular Vaccine Adjuvants Product Portfolio
6.10.5 InvivoGen Recent Developments/Updates
6.11 Merck KGaA
6.11.1 Merck KGaA Corporation Information
6.11.2 Merck KGaA Intramuscular Vaccine Adjuvants Description and Business Overview
6.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck KGaA Intramuscular Vaccine Adjuvants Product Portfolio
6.11.5 Merck KGaA Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Corporation Information
6.12.2 CSL Limited Intramuscular Vaccine Adjuvants Description and Business Overview
6.12.3 CSL Limited Intramuscular Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CSL Limited Intramuscular Vaccine Adjuvants Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular Vaccine Adjuvants Industry Chain Analysis
7.2 Intramuscular Vaccine Adjuvants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular Vaccine Adjuvants Production Mode & Process
7.4 Intramuscular Vaccine Adjuvants Sales and Marketing
7.4.1 Intramuscular Vaccine Adjuvants Sales Channels
7.4.2 Intramuscular Vaccine Adjuvants Distributors
7.5 Intramuscular Vaccine Adjuvants Customers
8 Intramuscular Vaccine Adjuvants Market Dynamics
8.1 Intramuscular Vaccine Adjuvants Industry Trends
8.2 Intramuscular Vaccine Adjuvants Market Drivers
8.3 Intramuscular Vaccine Adjuvants Market Challenges
8.4 Intramuscular Vaccine Adjuvants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Intramuscular Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intramuscular Vaccine Adjuvants Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intramuscular Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intramuscular Vaccine Adjuvants Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intramuscular Vaccine Adjuvants Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intramuscular Vaccine Adjuvants, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Product Type & Application
Table 12. Global Key Manufacturers of Intramuscular Vaccine Adjuvants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intramuscular Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Vaccine Adjuvants as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intramuscular Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Intramuscular Vaccine Adjuvants Sales by Region (2018-2023) & (K Units)
Table 18. Global Intramuscular Vaccine Adjuvants Sales Market Share by Region (2018-2023)
Table 19. Global Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (K Units)
Table 20. Global Intramuscular Vaccine Adjuvants Sales Market Share by Region (2024-2034)
Table 21. Global Intramuscular Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2018-2023)
Table 23. Global Intramuscular Vaccine Adjuvants Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2024-2034)
Table 25. North America Intramuscular Vaccine Adjuvants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Intramuscular Vaccine Adjuvants Sales by Country (2018-2023) & (K Units)
Table 27. North America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 28. North America Intramuscular Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intramuscular Vaccine Adjuvants Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Intramuscular Vaccine Adjuvants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Intramuscular Vaccine Adjuvants Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 33. Europe Intramuscular Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intramuscular Vaccine Adjuvants Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Intramuscular Vaccine Adjuvants Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intramuscular Vaccine Adjuvants Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intramuscular Vaccine Adjuvants Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Intramuscular Vaccine Adjuvants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intramuscular Vaccine Adjuvants Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2018-2023)
Table 51. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Type (2024-2034)
Table 52. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2018-2023)
Table 53. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2024-2034)
Table 54. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2018-2023)
Table 57. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2024-2034)
Table 58. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2018-2023)
Table 59. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2024-2034)
Table 60. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Application (2018-2023)
Table 61. Global Intramuscular Vaccine Adjuvants Sales (K Units) by Application (2024-2034)
Table 62. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2018-2023)
Table 63. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2024-2034)
Table 64. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intramuscular Vaccine Adjuvants Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2018-2023)
Table 67. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2024-2034)
Table 68. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2018-2023)
Table 69. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2024-2034)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GSK Intramuscular Vaccine Adjuvants Product
Table 74. GSK Recent Developments/Updates
Table 75. Dynavax Technologies Corporation Information
Table 76. Dynavax Technologies Description and Business Overview
Table 77. Dynavax Technologies Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Dynavax Technologies Intramuscular Vaccine Adjuvants Product
Table 79. Dynavax Technologies Recent Developments/Updates
Table 80. Novavax Corporation Information
Table 81. Novavax Description and Business Overview
Table 82. Novavax Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novavax Intramuscular Vaccine Adjuvants Product
Table 84. Novavax Recent Developments/Updates
Table 85. Agenus Corporation Information
Table 86. Agenus Description and Business Overview
Table 87. Agenus Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Agenus Intramuscular Vaccine Adjuvants Product
Table 89. Agenus Recent Developments/Updates
Table 90. Croda International Corporation Information
Table 91. Croda International Description and Business Overview
Table 92. Croda International Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Croda International Intramuscular Vaccine Adjuvants Product
Table 94. Croda International Recent Developments/Updates
Table 95. Seppic Corporation Information
Table 96. Seppic Description and Business Overview
Table 97. Seppic Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Seppic Intramuscular Vaccine Adjuvants Product
Table 99. Seppic Recent Developments/Updates
Table 100. OZ Biosciences Corporation Information
Table 101. OZ Biosciences Description and Business Overview
Table 102. OZ Biosciences Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. OZ Biosciences Intramuscular Vaccine Adjuvants Product
Table 104. OZ Biosciences Recent Developments/Updates
Table 105. Phibro Animal Health Corporation Information
Table 106. Phibro Animal Health Description and Business Overview
Table 107. Phibro Animal Health Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Phibro Animal Health Intramuscular Vaccine Adjuvants Product
Table 109. Phibro Animal Health Recent Developments/Updates
Table 110. Associated British Foods Corporation Information
Table 111. Associated British Foods Description and Business Overview
Table 112. Associated British Foods Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Associated British Foods Intramuscular Vaccine Adjuvants Product
Table 114. Associated British Foods Recent Developments/Updates
Table 115. InvivoGen Corporation Information
Table 116. InvivoGen Description and Business Overview
Table 117. InvivoGen Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. InvivoGen Intramuscular Vaccine Adjuvants Product
Table 119. InvivoGen Recent Developments/Updates
Table 120. Merck KGaA Corporation Information
Table 121. Merck KGaA Description and Business Overview
Table 122. Merck KGaA Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck KGaA Intramuscular Vaccine Adjuvants Product
Table 124. Merck KGaA Recent Developments/Updates
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Business Overview
Table 127. CSL Limited Intramuscular Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. CSL Limited Intramuscular Vaccine Adjuvants Product
Table 129. CSL Limited Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Intramuscular Vaccine Adjuvants Distributors List
Table 133. Intramuscular Vaccine Adjuvants Customers List
Table 134. Intramuscular Vaccine Adjuvants Market Trends
Table 135. Intramuscular Vaccine Adjuvants Market Drivers
Table 136. Intramuscular Vaccine Adjuvants Market Challenges
Table 137. Intramuscular Vaccine Adjuvants Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intramuscular Vaccine Adjuvants
Figure 2. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Intramuscular Vaccine Adjuvants Market Share by Type in 2024 & 2034
Figure 4. Infectious Diseases Product Picture
Figure 5. Cancer Product Picture
Figure 6. Others Product Picture
Figure 7. Global Intramuscular Vaccine Adjuvants Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Intramuscular Vaccine Adjuvants Market Share by Application in 2024 & 2034
Figure 9. Research Applications
Figure 10. Commercial Applications
Figure 11. Global Intramuscular Vaccine Adjuvants Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Intramuscular Vaccine Adjuvants Market Size (2018-2034) & (US$ Million)
Figure 13. Global Intramuscular Vaccine Adjuvants Sales (2018-2034) & (K Units)
Figure 14. Global Intramuscular Vaccine Adjuvants Average Price (US$/Unit) & (2018-2034)
Figure 15. Intramuscular Vaccine Adjuvants Report Years Considered
Figure 16. Intramuscular Vaccine Adjuvants Sales Share by Manufacturers in 2024
Figure 17. Global Intramuscular Vaccine Adjuvants Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Intramuscular Vaccine Adjuvants Players: Market Share by Revenue in 2024
Figure 19. Intramuscular Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Intramuscular Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Intramuscular Vaccine Adjuvants Sales Market Share by Country (2018-2034)
Figure 22. North America Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2018-2034)
Figure 23. United States Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Country (2018-2034)
Figure 26. Europe Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2018-2034)
Figure 27. Germany Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Intramuscular Vaccine Adjuvants Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2018-2034)
Figure 34. China Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Intramuscular Vaccine Adjuvants Sales Market Share by Country (2018-2034)
Figure 44. Latin America Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Intramuscular Vaccine Adjuvants Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Intramuscular Vaccine Adjuvants by Type (2018-2034)
Figure 54. Global Revenue Market Share of Intramuscular Vaccine Adjuvants by Type (2018-2034)
Figure 55. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Intramuscular Vaccine Adjuvants by Application (2018-2034)
Figure 57. Global Revenue Market Share of Intramuscular Vaccine Adjuvants by Application (2018-2034)
Figure 58. Global Intramuscular Vaccine Adjuvants Price (US$/Unit) by Application (2018-2034)
Figure 59. Intramuscular Vaccine Adjuvants Value Chain
Figure 60. Intramuscular Vaccine Adjuvants Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed